Jacques-Emmanuel Galimard Selected Research

Haploidentical Transplantation

1/2024	Matched unrelated donor transplantation versus haploidentical transplantation with post-transplant cyclophosphamide in children with acute myeloid leukemia: a PDWP-EBMT study.
1/2022	Post-transplant cyclophosphamide in one-antigen mismatched unrelated donor transplantation versus haploidentical transplantation in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the EBMT.
1/2022	Reduced intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid leukemia: a study from the ALWP of the EBMT.
1/2021	Outcomes of Unmanipulated Haploidentical Transplantation Using Post-Transplant Cyclophosphamide (PT-Cy) in Pediatric Patients With Acute Lymphoblastic Leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jacques-Emmanuel Galimard Research Topics

Disease

14	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2024 - 01/2020
8	Leukemia 12/2023 - 01/2022
3	Neoplasms (Cancer) 03/2021 - 11/2019
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 01/2020
2	Hemolysis 04/2024 - 01/2023
2	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2022 - 01/2020
2	Pathologic Complete Response 10/2022 - 01/2022
1	Edema (Dropsy) 04/2024
1	Infections 04/2024
1	Hematoma 04/2024
1	Phlebitis 04/2024
1	Primary Myelofibrosis (Myelosclerosis) 04/2024
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 02/2024
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 02/2024
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2024
1	Sickle Cell Anemia (Hemoglobin S Disease) 10/2023
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/2023
1	Thrombotic Microangiopathies 01/2023
1	Thrombosis (Thrombus) 01/2023
1	Aplastic Anemia (Anemia, Hypoplastic) 01/2023
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023
1	beta-Thalassemia (Cooley's Anemia) 03/2022
1	Pure Red-Cell Aplasia 01/2021
1	Iron Overload 01/2021
1	Bronchiolitis Obliterans Syndrome 11/2019

Drug/Important Bio-Agent (IBA)

7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2024 - 01/2020
3	fludarabineIBA 12/2023 - 03/2022
2	Busulfan (Busulfex)FDA Link 10/2023 - 03/2022
2	treosulfanIBA 10/2023 - 03/2022
2	Complement System Proteins (Complement)IBA 01/2023 - 01/2023
2	eculizumab FDA Link 01/2023 - 01/2023
1	Polyvinyl Chloride (PVC)IBA 04/2024
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 12/2023
1	Melphalan (Alkeran)FDA LinkGeneric 12/2023
1	Carmustine (FIVB)FDA Link 12/2023
1	Complement Factor H (Factor H)IBA 01/2023
1	Monoclonal AntibodiesIBA 01/2023
1	AntigensIBA 01/2022

Therapy/Procedure

15	Transplantation 04/2024 - 11/2019
9	Stem Cell Transplantation 05/2024 - 01/2020
7	Hematopoietic Stem Cell Transplantation 02/2024 - 11/2019
4	Haploidentical Transplantation 01/2024 - 01/2021
2	Cell Transplantation 04/2024 - 01/2023
2	Drug Therapy (Chemotherapy) 01/2023 - 01/2020
1	Catheters 04/2024
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 04/2024
1	Homologous Transplantation 01/2023
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 10/2022